In each subsection (e.g., Device Description, Risk Management), FDA indicates where in the submission the recommended information should be provided. Appendix A to the draft guidance also provides ...

The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five clinical sites. The Company believes the study's findings support the clinical ...